Compare PATK & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PATK | VCYT |
|---|---|---|
| Founded | 1959 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.1B |
| IPO Year | 1994 | 2013 |
| Metric | PATK | VCYT |
|---|---|---|
| Price | $84.87 | $55.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $122.75 | $44.00 |
| AVG Volume (30 Days) | 904.9K | ★ 1.0M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | ★ 1.10 | 0.35 |
| Revenue | ★ $29,000,000.00 | N/A |
| Revenue This Year | $5.78 | $13.76 |
| Revenue Next Year | $6.51 | $12.35 |
| P/E Ratio | ★ $76.82 | $161.74 |
| Revenue Growth | ★ 262.50 | N/A |
| 52 Week Low | $81.29 | $22.92 |
| 52 Week High | $148.50 | $60.91 |
| Indicator | PATK | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 44.21 | 50.46 |
| Support Level | $82.49 | $54.25 |
| Resistance Level | $90.28 | $60.86 |
| Average True Range (ATR) | 2.72 | 2.58 |
| MACD | 0.08 | -0.69 |
| Stochastic Oscillator | 35.48 | 28.39 |
Patrick Industries Inc is a component solutions provider for the recreational vehicle (RV), marine, powersports, manufactured housing (MH), and various industrial markets, including single and multi-family housing, hospitality, institutional, and commercial markets. The company operates within two reportable segments, Manufacturing and Distribution. The majority of its revenue is generated from the Manufacturing segment, which offers laminated products utilized to produce furniture, shelving, walls, and countertops; fabricated aluminum products; cabinet products, doors, components, and custom cabinetry; interior passage doors and baggage doors; RV and marine furniture, etc. Geographically, the company mainly operates in the United States, with a small presence in Mexico, China, and Canada.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).